vs
Indivior Pharmaceuticals, Inc.（INDV）与Real Brokerage Inc（REAX）财务数据对比。点击上方公司名可切换其他公司
Real Brokerage Inc的季度营收约是Indivior Pharmaceuticals, Inc.的1.6倍（$568.5M vs $357.0M），Indivior Pharmaceuticals, Inc.净利率更高（28.9% vs -0.1%，领先28.9%），Real Brokerage Inc自由现金流更多（$8.4M vs $-245.0M）
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
该企业是美国房产服务企业，主营房产经纪业务运营与品牌特许经营，业务覆盖房产中介、 relocation服务、产权服务、保险及结算服务，旗下拥有Better Homes and Gardens Real Estate、21世纪不动产、Coldwell Banker、Corcoran Group、ERA房地产以及苏富比国际地产等多个知名品牌，2026年被Compass, Inc.收购。
INDV vs REAX — 直观对比
营收规模更大
REAX
是对方的1.6倍
$357.0M
净利率更高
INDV
高出28.9%
-0.1%
自由现金流更多
REAX
多$253.4M
$-245.0M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $357.0M | $568.5M |
| 净利润 | $103.0M | $-447.0K |
| 毛利率 | 82.1% | 7.9% |
| 营业利润率 | 22.7% | -0.1% |
| 净利率 | 28.9% | -0.1% |
| 营收同比 | — | 52.6% |
| 净利润同比 | 390.5% | 82.7% |
| 每股收益（稀释后） | $0.79 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INDVREAX
| Q4 25 | $357.0M | — | ||
| Q3 25 | $314.0M | $568.5M | ||
| Q2 25 | $302.0M | $540.7M | ||
| Q1 25 | $266.0M | $354.0M | ||
| Q3 24 | $307.0M | $372.5M | ||
| Q2 24 | $299.0M | — | ||
| Q1 24 | — | $200.7M |
净利润INDVREAX
| Q4 25 | $103.0M | — | ||
| Q3 25 | $42.0M | $-447.0K | ||
| Q2 25 | $18.0M | $1.5M | ||
| Q1 25 | $47.0M | $-5.0M | ||
| Q3 24 | $22.0M | $-2.6M | ||
| Q2 24 | $-97.0M | — | ||
| Q1 24 | — | $-16.1M |
毛利率INDVREAX
| Q4 25 | 82.1% | — | ||
| Q3 25 | 73.2% | 7.9% | ||
| Q2 25 | 82.8% | 8.9% | ||
| Q1 25 | 83.1% | 9.6% | ||
| Q3 24 | 78.5% | 8.6% | ||
| Q2 24 | 73.6% | — | ||
| Q1 24 | — | 10.3% |
营业利润率INDVREAX
| Q4 25 | 22.7% | — | ||
| Q3 25 | 13.7% | -0.1% | ||
| Q2 25 | 23.8% | 0.3% | ||
| Q1 25 | 24.8% | -1.5% | ||
| Q3 24 | 11.4% | -0.7% | ||
| Q2 24 | -39.5% | — | ||
| Q1 24 | — | -7.8% |
净利率INDVREAX
| Q4 25 | 28.9% | — | ||
| Q3 25 | 13.4% | -0.1% | ||
| Q2 25 | 6.0% | 0.3% | ||
| Q1 25 | 17.7% | -1.4% | ||
| Q3 24 | 7.2% | -0.7% | ||
| Q2 24 | -32.4% | — | ||
| Q1 24 | — | -8.0% |
每股收益（稀释后）INDVREAX
| Q4 25 | $0.79 | — | ||
| Q3 25 | $0.33 | $0.00 | ||
| Q2 25 | $0.14 | $0.01 | ||
| Q1 25 | $0.38 | $-0.02 | ||
| Q3 24 | $0.16 | $-0.01 | ||
| Q2 24 | $-0.72 | — | ||
| Q1 24 | — | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.0M | $38.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-98.0M | $53.6M |
| 总资产 | $1.2B | $145.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INDVREAX
| Q4 25 | $195.0M | — | ||
| Q3 25 | $445.0M | $38.7M | ||
| Q2 25 | $510.0M | $49.7M | ||
| Q1 25 | $373.0M | $24.7M | ||
| Q3 24 | — | $22.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $20.1M |
股东权益INDVREAX
| Q4 25 | $-98.0M | — | ||
| Q3 25 | $-207.0M | $53.6M | ||
| Q2 25 | $-257.0M | $49.2M | ||
| Q1 25 | $-285.0M | $32.8M | ||
| Q3 24 | $-310.0M | $29.8M | ||
| Q2 24 | $-281.0M | — | ||
| Q1 24 | — | $25.6M |
总资产INDVREAX
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.4B | $145.2M | ||
| Q2 25 | $1.5B | $149.4M | ||
| Q1 25 | $1.4B | $100.5M | ||
| Q3 24 | — | $102.5M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-221.0M | $8.8M |
| 自由现金流经营现金流 - 资本支出 | $-245.0M | $8.4M |
| 自由现金流率自由现金流/营收 | -68.6% | 1.5% |
| 资本支出强度资本支出/营收 | 6.7% | 0.1% |
| 现金转化率经营现金流/净利润 | -2.15× | — |
| 过去12个月自由现金流最近4个季度 | $-93.0M | $71.7M |
8季度趋势，按日历期对齐
经营现金流INDVREAX
| Q4 25 | $-221.0M | — | ||
| Q3 25 | $-39.0M | $8.8M | ||
| Q2 25 | $158.0M | $41.0M | ||
| Q1 25 | $75.0M | $15.9M | ||
| Q3 24 | $2.0M | $7.2M | ||
| Q2 24 | $88.0M | — | ||
| Q1 24 | — | $21.5M |
自由现金流INDVREAX
| Q4 25 | $-245.0M | — | ||
| Q3 25 | $-59.0M | $8.4M | ||
| Q2 25 | $141.0M | $40.8M | ||
| Q1 25 | $70.0M | $15.7M | ||
| Q3 24 | $-5.0M | $6.8M | ||
| Q2 24 | $84.0M | — | ||
| Q1 24 | — | $21.4M |
自由现金流率INDVREAX
| Q4 25 | -68.6% | — | ||
| Q3 25 | -18.8% | 1.5% | ||
| Q2 25 | 46.7% | 7.5% | ||
| Q1 25 | 26.3% | 4.4% | ||
| Q3 24 | -1.6% | 1.8% | ||
| Q2 24 | 28.1% | — | ||
| Q1 24 | — | 10.7% |
资本支出强度INDVREAX
| Q4 25 | 6.7% | — | ||
| Q3 25 | 6.4% | 0.1% | ||
| Q2 25 | 5.6% | 0.0% | ||
| Q1 25 | 1.9% | 0.1% | ||
| Q3 24 | 2.3% | 0.1% | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | — | 0.0% |
现金转化率INDVREAX
| Q4 25 | -2.15× | — | ||
| Q3 25 | -0.93× | — | ||
| Q2 25 | 8.78× | 27.13× | ||
| Q1 25 | 1.60× | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
REAX
暂无分部数据
